A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Tanya Simuni(Northwestern University), Lana M. Chahine(University of Pittsburgh), Kathleen L. Poston(Stanford University), Michael C. Brumm(University of Iowa), Teresa Buracchio(Center for Drug Evaluation and Research), Michelle Campbell(Center for Drug Evaluation and Research), Sohini Chowdhury(Michael J. Fox Foundation), Christopher S. Coffey(University of Iowa), Luis Concha‐Marambio(Amprion (United States)), Tien Dam(Biogen (United States)), Peter DiBiaso(Clinical Solutions), Tatiana Foroud(Indiana University – Purdue University Indianapolis), Mark Frasier(Michael J. Fox Foundation), Caroline Gochanour(University of Iowa), Danna Jennings(Denali Therapeutics (United States)), Karl Kieburtz(University of Rochester Medical Center), Catherine Kopil(Michael J. Fox Foundation), Kalpana Merchant(Northwestern University), Brit Mollenhauer(Universitätsmedizin Göttingen), Thomas J. Montine(Stanford University), Kelly Nudelman(Indiana University – Purdue University Indianapolis), Gennaro Pagano(Roche (Switzerland)), John Seibyl(Institute for Neurodegenerative Disorders), Todd Sherer(Michael J. Fox Foundation), Andrew Singleton(National Institutes of Health), Diane Stephenson(Critical Path Institute), Matthew Stern(University of Pennsylvania), Claudio Soto(Amprion (United States)), Caroline M. Tanner(University of California, San Francisco), Eduardo Tolosa(Universitat de Barcelona), Daniel Weintraub(Mental Illness Research, Education and Clinical Centers), Yuge Xiao(Michael J. Fox Foundation), Andrew Siderowf(University of Pennsylvania), Billy Dunn(Michael J. Fox Foundation), Kenneth Marek(Institute for Neurodegenerative Disorders)
Cited by 548Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis